InvestorsHub Logo

arvitar

11/17/17 3:16 PM

#136181 RE: Ubertino #136180

Glaxo, or anyone else interested in Diwan's aging patent in these imaginary scenarios that don't make sense, would only deal with the entity who owns the patent.

NNVC is not that entity.